Race Oncology Ltd

RAC · AU · Healthcare / Biotechnology

1.58AUD+0.00 (+0.32%)

Price History

Full chart

Market Stats

Previous Close1.57

Open1.60

Day Range1.52 – 1.60

52-Week Range1.84 – 4.90

Volume67.70K

Market Cap376.45M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.06

Dividend Yield0.00%

Beta0.83

50-Day Avg2.05

200-Day Avg2.40

About

Racura Oncology Ltd operates as a clinical-stage biopharmaceutical company in Australia. It develops RC220, a formulation of (E,E)-bisantrene, which is in Phase III clinical trial for the treatment of acute myeloid leukemia; Phase Ia/b clinical trial for the treatment of epidermal growth factor receptor-mutated non-small cell lung cancer; and Phase Ia/b clinical trial for the treatment of solid tumor cancers. The company was formerly known as Race Oncology Limited and changed its name to Racura Oncology Ltd in December 2025. Racura Oncology Ltd was incorporated in 2011 and is headquartered in Sydney, Australia.

Company Details

SectorHealthcare
IndustryBiotechnology
CEODr. Daniel Tillett
Employees0
HeadquartersGateway, 1 Macquarie Place, Sydney, NSW, Australia, 2000, Australia
Websitehttps://racuraoncology.com

Leadership

Dr. Peter Michael Smith Ph.D.Executive Chairman · b. 1963
Dr. Daniel TillettCEO, MD & Director
Mr. Brendan BrownChief Financial Officer
Dr. Sophia MoscovisVice President of Operations & Strategy
Dr. Jose L. Iglesias M.D.Chief Medical Officer · b. 1957
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.Company Secretary · b. 1963

Financials

Income Statement

Currency: AUD	2011-06-30	2012-06-30	2012-12-31	2013-06-30	2013-12-31	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Revenue	124.81M	140.92M	85.29M	-	71.14M	0	490	16.98K	25.21K	170.26K	228.50K	159.37K	387.38K	707.81K	3.13M	4.00M	6.04M	-
Growth (%)	-	+12.90%	-39.47%	-	-	-100.00%	-	+3365.31%	+48.47%	+575.37%	+34.21%	-30.25%	+143.07%	+82.71%	+342.78%	+27.73%	+50.96%	-
Cost of Revenue	90.42M	135.41M	77.75M	-	90.10M	0	0	0	250.00K	250.87K	281.20K	281.20K	281.20K	281.20K	281.20K	281.20K	635.21K	281.31K
Gross Profit	34.39M	5.51M	7.54M	-	-18.96M	0	0	0	-250.00K	-80.60K	-52.70K	-122.00K	106.19K	426.61K	-281.20K	2.22M	5.41M	-281.31K
Gross Margin	27.55%	3.91%	8.84%	-	-26.65%	-	0.00%	0.00%	-991.67%	-47.34%	-23.06%	-76.55%	27.41%	60.27%	-8.97%	55.52%	89.49%	-
Operating Expense	26.04M	16.85M	6.35M	-	-25.05M	95.21K	78.22K	423.00K	3.79M	6.25M	3.71M	3.84M	6.58M	11.91M	12.71M	20.06M	9.18M	12.15M
Operating Income	8.35M	-11.34M	1.19M	-13.12K	6.09M	-95.21K	-78.22K	-423.00K	-4.04M	-6.33M	-3.76M	-3.96M	-6.48M	-11.49M	-12.99M	-17.83M	-3.77M	-12.43M
Operating Margin	6.69%	-8.05%	1.39%	-	8.56%	-	-15963.67%	-2491.17%	-16033.32%	-3717.21%	-1646.82%	-2484.77%	-1671.72%	-1622.76%	-414.39%	-445.48%	-62.42%	-
EBITDA	-	-	-	-40.15K	-	2.84K	3.45K	-496.20K	-3.93M	-6.23M	-3.61M	-3.72M	-6.45M	-11.63M	-12.78M	-14.20M	-4.43M	-12.15M
EBITDA Margin	-	-	-	-	-	-	704.90%	-2922.26%	-15604.92%	-3656.72%	-1578.55%	-2336.69%	-1664.24%	-1642.96%	-407.69%	-354.81%	-73.37%	-
Net Income	10.12M	-10.25M	1.09M	-10.15K	6.15M	-92.37K	-87.27K	-318.00K	-4.17M	-6.31M	-3.66M	-3.85M	-6.34M	-11.20M	-9.92M	-13.82M	-4.79M	-11.09M
Net Income Margin	8.11%	-7.27%	1.28%	-	8.65%	-	-17810.00%	-1872.79%	-16548.99%	-3703.70%	-1601.31%	-2413.24%	-1636.61%	-1582.63%	-316.62%	-345.22%	-79.22%	-
R&D	-	-	-	-	-	1.21M	1.21M	1.21M	1.21M	1.75M	1.36M	1.72M	2.20M	5.83M	7.60M	10.98M	5.90M	7.62M
R&D as % of Total Revenue	-	-	-	-	-	-	247056.12%	7129.42%	4803.65%	1025.48%	597.37%	1079.24%	567.91%	823.95%	242.37%	274.22%	97.58%	-
Interest Expense	0	0	0	0	0	0	0	1.23K	0	0	0	0	0	53.91K	-	-	-	-
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	-	0.00%	-	0.00%	7.24%	0.00%	0.00%	0.00%	0.00%	0.00%	7.62%	-	-	-	-

Balance Sheet

Currency: AUD	2011-06-30	2012-06-30	2012-12-31	2013-06-30	2013-12-31	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Assets	380.25M	425.96M	360.83M	105.23K	289.97M	61.80K	124.47K	4.47M	6.00M	8.24M	5.24M	5.93M	14.25M	37.52M	26.64M	20.23M	17.49M	38.09M
Total Liabilities	273.20M	331.51M	264.98M	11.85K	191.01M	132.05K	118.78K	391.62K	363.57K	309.71K	192.12K	243.65K	523.11K	1.42M	1.15M	1.92M	1.48M	1.64M
Total Equity	107.05M	94.45M	95.85M	93.38K	98.97M	-70.24K	5.69K	4.08M	5.64M	7.93M	5.05M	5.69M	13.72M	36.11M	25.49M	18.31M	16.01M	36.45M
Cash	10.30M	40.14M	19.13M	104.19K	25.62M	48.28K	21.29K	4.35M	1.70M	3.71M	988.71K	1.73M	9.32M	6.04M	1.92M	17.19M	13.67M	34.29M
Total Debt	-	-	-	-	-	-	-	5.25K	-	-	-	-	-	-	-	-	-	-
Net Debt	-	-	-	-104.19K	-	-48.28K	-21.29K	-4.34M	-1.70M	-3.71M	-988.71K	-1.73M	-9.32M	-6.04M	-1.92M	-17.19M	-13.67M	-34.29M

Cash Flow

Currency: AUD	2011-06-30	2012-06-30	2013-06-30	2013-12-31	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Operating Cash Flow	11.92M	6.68M	-1.90K	3.71M	-39.56K	-103.69K	-306.06K	-2.47M	-3.87M	-2.67M	-2.46M	-4.70M	-6.26M	-10.65M	-9.55M	-4.57M	-8.25M
Investing Cash Flow	8.12M	31.91M	9.79M	3.73M	-16.35K	-86.50K	1.00K	100.67K	0	0	0	-	-	7.90M	0	0	-3.14K
Financing Cash Flow	-23.09M	-6.78M	320.00K	-3.36M	163.20K	163.20K	4.63M	-269.25K	5.92M	-33.84K	3.21M	12.28M	30.51M	-1.28M	5.21M	1.06M	28.87M
Capital Expenditure	72.00K	218.00K	31.00K	31.00K	0	0	0	0	0	0	0	0	3	0	1	3	3.67K
Free Cash Flow	-	-	-1.90K	-	-39.56K	-103.69K	-306.06K	-2.47M	-3.87M	-2.67M	-2.46M	-4.70M	-6.26M	-10.65M	-9.55M	-4.57M	-8.25M
Dividends Paid	2.31M	2.27M	2.04M	2.04M	-	-	4.63M	533.25K	-	-	-	-	-	-	-	-	-
FCF to OCF	-	-	100.00%	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.04%
Dividend Paid to FCF	-	-	-107424.96%	-	-	-	-1512.89%	-21.62%	-	-	-	-	-	-	-	-	-

Earnings

Report Date	Jul 11, 2016	Feb 24, 2017	Aug 29, 2017	Feb 20, 2018	Aug 21, 2018	Feb 27, 2019	Aug 23, 2019	Feb 25, 2020	Aug 27, 2020	Feb 25, 2021	Aug 26, 2021	Feb 25, 2022	Aug 26, 2022	Feb 27, 2023	Feb 25, 2025	Aug 26, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	0.00	0.00
EPS Actual	0.00	-0.04	-0.04	-0.05	-0.04	-0.03	-0.02	-0.02	-0.02	-0.02	-0.03	-0.03	-0.04	-0.03	0.00	-0.03
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	After-hours	-	-

Key Statistics & Ratios

Market Cap376.45M

Enterprise Value355.89M

Trailing P/E0.00

Forward P/E0.00

Price / Sales133.92

Price / Book10.71

EPS-0.06

Book Value0.186

Revenue (TTM)2.81M

Gross Profit (TTM)1.72M

EBITDA-10.12M

Profit Margin0.00%

Operating Margin-370.08%

Return on Equity-42.28%

Return on Assets-23.40%

Shares Outstanding196.07M

Shares Float136.32M

Beta0.83

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%